
TOKYO/HONG KONG -- Initial public offerings in the Hong Kong market surged during the first six months of 2019, despite concerns about the city's relationship with mainland China and the outbreak of mass protests.
Analysts expect looser rules on biotech companies to maintain momentum
TOKYO/HONG KONG -- Initial public offerings in the Hong Kong market surged during the first six months of 2019, despite concerns about the city's relationship with mainland China and the outbreak of mass protests.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.